The Gene Expression Resource (GER) was established with the successful recruitment ofLesleyann Hawthorn, PhD in 2001. The Resource has flourished since that time with a broad base ofsatisfied users whose continued patronage is derived from a unique approach to microarrayexperimentation. Its success is largely due to a commitment to provide researchers with high-qualitymicroarray data with the added advantage of data analysis so that the results provided to the individualresearchers are in a usable format, unlike most array-based facilities. Dr Hawthorn and the GER staff keepabreast of emerging technologies to provide users with a broad range of expertise and options. This successis substantiated by a large user base, publications and awarded grants. The Resource is functionally dividedinto Gene Expression, Genotyping, and Copy Number Analysis at the genomics level. At the level ofindividual chromosomal regions or specific genes, it offers mutation/polymorphism analysis, SNP validationand discovery, expression level quantification and analysis of methylation status. Most importantly, theResource offers data analysis for all the platforms that it supports and provides expertise, time and fundingfor the development of novel technologies. For example, Exon array analysis has been developed whichallows simultaneous detection of gene expression and alternative splicing events. Furthermore, theResource is now able to run Whole-Genome Tiling arrays, which permit the highest-resolution Chip-on-Chipanalysis as well as the detection of novel transcripts in genomic DNA. During the last few years, theResource has been working on innovative approaches to the analysis of genomics data. One of thesecenters on the high-density SNP arrays that offer the highest density genotyping, as well as simultaneousCGH analysis with accompanying LOH analysis. Gene Expression has been using these arrays to look forgains and losses of chromosomal regions (CGH). The ability of the SNP Mapping arrays to detect standardcytogenetic abnormalities represents a major advancement over conventional karyotyping. The GER hascollaborated with Dr Cowell's group (GN) to develop statistical analysis tools that permit the overlay of geneexpression data with aCGH data, thus enhancing the power of both these technologies. Members of the sixCCSG programs utilized this Resource over the last project period. The Resource was instrumental inenhanced peer-reviewed funding, publications and recruitment efforts. It is anticipated that with the newrecruitment into the CSBT Program (Dr Gudkov), MTET Program (Dr Adjei), and Til (Dr Lee) the utilization ofthe Resource will expand. The Resource is used by all six Programs and 98% of users are CCSGmembers. $80,355 in CCSG support is requested, representing 11% of the total operating budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-32
Application #
7714418
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-28
Project End
2013-04-30
Budget Start
2008-07-28
Budget End
2009-04-30
Support Year
32
Fiscal Year
2008
Total Cost
$67,541
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Rossetti, Stefano; Wierzbicki, Andrzej J; Sacchi, Nicoletta (2018) Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer. Oncotarget 9:5016-5031
Block, Matthew S; Vierkant, Robert A; Rambau, Peter F et al. (2018) MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. Mayo Clin Proc 93:307-320
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Kawaguchi, Tstutomu; Yan, Li; Qi, Qianya et al. (2018) Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Ann Surg Oncol 25:4037-4046
Mett, V; Komarova, E A; Greene, K et al. (2018) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:439-449
Long, Mark D; Singh, Prashant K; Russell, James R et al. (2018) The miR-96 and RAR? signaling axis governs androgen signaling and prostate cancer progression. Oncogene :
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Yendamuri, Sai; Groman, Adrienne; Miller, Austin et al. (2018) Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. Eur J Cardiothorac Surg 53:656-663

Showing the most recent 10 out of 1555 publications